Concepedia

Emel Girit

EG

4

Publications

165

Citations

4

H-Index

1978

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Emel Girit is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and tumor microenvironment.

Top concepts

MedicineImmunologyOncologyPharmacologyTumor BiologyTumor MicroenvironmentImmunotherapyCancer TherapyTumor ImmunityCancer Research

Publications per year

1978–2013

4

Publications

4

Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models

Maria Jure–Kunkel, Gregg Masters, Emel Girit et al. · Cancer Immunology Immunotherapy · 2013 · 84 citations · Full text

Chemotherapeutic Agents, Therapeutic Synergy, Cancer Immunosurveillance +15

Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin.

Pamela A. Trail, David Willner, A. Bianchi et al. · PubMed · 1999 · 44 citations

Oncology, Antitumor Activity, Regression Rates +13

Antitumor activity of anti-CTLA-4 monoclonal antibody (mAb) in combination with ixabepilone in preclinical tumor models

Maria Jure‐Kunkel, Gregg Masters, Emel Girit et al. · Journal of Clinical Oncology · 2008 · 20 citations

Antitumor Activity, Immunology, Immunoediting +22

Changes in intracellular prostaglandin content during activation of lymphocytes by phytohaemagglutinin

Emel Girit, John E. Kay · FEBS Letters · 1978 · 17 citations · Full text

Inflammation, Intracellular Prostaglandin Content, Signal Transduction +12

Rows per page

1–4 of 4